Patients and caregivers should be included as equal partners in the drug development process, particularly for rare conditions where limitations on what we know about a disease may exist. Rare disease nonprofit organizations can drive research and data collection efforts that may be leveraged to guide researchers toward meaningful outcomes and patient-centric clinical trial designs. Read more >
Find out more »
